The global influenza diagnostic equipment market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. Influenza is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and lungs. It can cause mild to severe illness and can lead to death in some cases. The virus spreads mainly through droplets from coughing or sneezing and less often through contact with contaminated surfaces or objects. Influenza diagnostic tests (RIDT) are used for diagnosis of influenza infection in humans by detecting antibodies against the virus in blood serum or nasal swabs; reverse transcription polymerase chain reaction (RPCR) is used for detection of viral RNA sequences; cell culture is used for detection of viral antigens in cells grown on a nutrient medium under controlled conditions. The hospital segment accounted for the largest share of the global market due to high prevalence rates among patients admitted at hospitals as well as increased awareness among healthcare professionals about prevention methods such as vaccination and antiviral drugs which are available only at hospitals.
- The increasing number of people with chronic diseases such as diabetes and asthma, which are more susceptible to influenza.
- The increasing number of elderly people in the population.
- The increase in the number of children attending daycare centers and schools.
- The increased use of diagnostic equipment for other purposes such as HIV testing.
- Increasing awareness about influenza.
Industry Growth Insights published a new data on “Influenza Diagnostic Equipment Market”. The research report is titled “Influenza Diagnostic Equipment Market research by Types (Influenza diagnostic tests (RIDT), Reverse transcription polymerase chain reaction (RT-PCR), Cell culture, Others), By Applications (Hospital, POTC, Laboratories), By Players/Companies BD Medical, Abbott laboratories, Thermo Fisher Scientific, Roche Diagnostics, Alere Inc., Quidel Corporation, Sekisui Diagnostics, DiaSorin, SA Scientific, Luminex Corporation”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Influenza Diagnostic Equipment Market Research Report
By Type
Influenza diagnostic tests (RIDT), Reverse transcription polymerase chain reaction (RT-PCR), Cell culture, Others
By Application
Hospital, POTC, Laboratories
By Companies
BD Medical, Abbott laboratories, Thermo Fisher Scientific, Roche Diagnostics, Alere Inc., Quidel Corporation, Sekisui Diagnostics, DiaSorin, SA Scientific, Luminex Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Influenza Diagnostic Equipment Market Report Segments:
The global Influenza Diagnostic Equipment market is segmented on the basis of:
Types
Influenza diagnostic tests (RIDT), Reverse transcription polymerase chain reaction (RT-PCR), Cell culture, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, POTC, Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD Medical
- Abbott laboratories
- Thermo Fisher Scientific
- Roche Diagnostics
- Alere Inc.
- Quidel Corporation
- Sekisui Diagnostics
- DiaSorin
- SA Scientific
- Luminex Corporation
Highlights of The Influenza Diagnostic Equipment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Influenza diagnostic tests (RIDT)
- Reverse transcription polymerase chain reaction (RT-PCR)
- Cell culture
- Others
- By Application:
- Hospital
- POTC
- Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Influenza Diagnostic Equipment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Influenza diagnostic equipment is a medical device that helps doctors diagnose the flu. This equipment can include a microscope, test tubes, and other tools to help identify the virus and determine if someone has the flu.
Some of the key players operating in the influenza diagnostic equipment market are BD Medical, Abbott laboratories, Thermo Fisher Scientific, Roche Diagnostics, Alere Inc., Quidel Corporation, Sekisui Diagnostics, DiaSorin, SA Scientific, Luminex Corporation.
The influenza diagnostic equipment market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Influenza Diagnostic Equipment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Influenza Diagnostic Equipment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Influenza Diagnostic Equipment Market - Supply Chain
4.5. Global Influenza Diagnostic Equipment Market Forecast
4.5.1. Influenza Diagnostic Equipment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Influenza Diagnostic Equipment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Influenza Diagnostic Equipment Market Absolute $ Opportunity
5. Global Influenza Diagnostic Equipment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Influenza Diagnostic Equipment Market Size and Volume Forecast by Type
5.3.1. Influenza diagnostic tests (RIDT)
5.3.2. Reverse transcription polymerase chain reaction (RT-PCR)
5.3.3. Cell culture
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Influenza Diagnostic Equipment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Influenza Diagnostic Equipment Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. POTC
6.3.3. Laboratories
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Influenza Diagnostic Equipment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Influenza Diagnostic Equipment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Influenza Diagnostic Equipment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Influenza Diagnostic Equipment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Influenza Diagnostic Equipment Demand Share Forecast, 2019-2026
9. North America Influenza Diagnostic Equipment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Influenza Diagnostic Equipment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Influenza Diagnostic Equipment Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. POTC
9.4.3. Laboratories
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Influenza Diagnostic Equipment Market Size and Volume Forecast by Type
9.7.1. Influenza diagnostic tests (RIDT)
9.7.2. Reverse transcription polymerase chain reaction (RT-PCR)
9.7.3. Cell culture
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Influenza Diagnostic Equipment Demand Share Forecast, 2019-2026
10. Latin America Influenza Diagnostic Equipment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Influenza Diagnostic Equipment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Influenza Diagnostic Equipment Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. POTC
10.4.3. Laboratories
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Influenza Diagnostic Equipment Market Size and Volume Forecast by Type
10.7.1. Influenza diagnostic tests (RIDT)
10.7.2. Reverse transcription polymerase chain reaction (RT-PCR)
10.7.3. Cell culture
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Influenza Diagnostic Equipment Demand Share Forecast, 2019-2026
11. Europe Influenza Diagnostic Equipment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Influenza Diagnostic Equipment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Influenza Diagnostic Equipment Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. POTC
11.4.3. Laboratories
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Influenza Diagnostic Equipment Market Size and Volume Forecast by Type
11.7.1. Influenza diagnostic tests (RIDT)
11.7.2. Reverse transcription polymerase chain reaction (R-PCR)
11.7.3. Cell culture
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Influenza Diagnostic Equipment Demand Share, 2019-2026
12. Asia Pacific Influenza Diagnostic Equipment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Influenza Diagnostic Equipment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Influenza Diagnostic Equipment Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. POTC
12.4.3. Laboratories
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Influenza Diagnostic Equipment Market Size and Volume Forecast by Type
12.7.1. Influenza diagnostic tests (RIDT)
12.7.2. Reverse transcription polymerase chain reaction (RT-PCR)
12.7.3. Cell culture
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Influenza Diagnostic Equipment Demand Share, 2019-2026
13. Middle East & Africa Influenza Diagnostic Equipment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Influenza Diagnostic Equipment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Influenza Diagnostic Equipment Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. POTC
13.4.3. Laboratories
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Influenza Diagnostic Equipment Market Size and Volume Forecast by Type
13.7.1. Influenza diagnostic tests (RIDT)
13.7.2. Reverse transcription polymerase chain reaction (RT-PCR)
13.7.3. Cell culture
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Influenza Diagnostic Equipment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Influenza Diagnostic Equipment Market: Market Share Analysis
14.2. Influenza Diagnostic Equipment Distributors and Customers
14.3. Influenza Diagnostic Equipment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BD Medical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbott laboratories
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Thermo Fisher Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Roche Diagnostics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Alere Inc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Quidel Corporation
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sekisui Diagnostics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. DiaSorin
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. SA Scientific
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Luminex Corporation
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
